These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 22211691)
1. Curcumin: a potential neuroprotective agent in Parkinson's disease. Mythri RB; Bharath MM Curr Pharm Des; 2012; 18(1):91-9. PubMed ID: 22211691 [TBL] [Abstract][Full Text] [Related]
2. Neuroprotective properties of curcumin in toxin-base animal models of Parkinson's disease: a systematic experiment literatures review. Wang XS; Zhang ZR; Zhang MM; Sun MX; Wang WW; Xie CL BMC Complement Altern Med; 2017 Aug; 17(1):412. PubMed ID: 28818104 [TBL] [Abstract][Full Text] [Related]
3. Neuroprotective Effect of Curcumin on the Nigrostriatal Pathway in a 6-Hydroxydopmine-Induced Rat Model of Parkinson's Disease is Mediated by α7-Nicotinic Receptors. El Nebrisi E; Javed H; Ojha SK; Oz M; Shehab S Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023066 [TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of curcumin-I in copper-induced dopaminergic neurotoxicity in rats: A possible link with Parkinson's disease. Abbaoui A; Chatoui H; El Hiba O; Gamrani H Neurosci Lett; 2017 Nov; 660():103-108. PubMed ID: 28919537 [TBL] [Abstract][Full Text] [Related]
5. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Zbarsky V; Datla KP; Parkar S; Rai DK; Aruoma OI; Dexter DT Free Radic Res; 2005 Oct; 39(10):1119-25. PubMed ID: 16298737 [TBL] [Abstract][Full Text] [Related]
6. Neuroprotective Activities of Curcumin in Parkinson's Disease: A Review of the Literature. Nebrisi EE Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681908 [TBL] [Abstract][Full Text] [Related]
7. Beneficial Effects of Flavonoids Against Parkinson's Disease. Jung UJ; Kim SR J Med Food; 2018 May; 21(5):421-432. PubMed ID: 29412767 [TBL] [Abstract][Full Text] [Related]
8. An Overview of Parkinson's Disease: Curcumin as a Possible Alternative Treatment. Patel A; Olang CA; Lewis G; Mandalaneni K; Anand N; Gorantla VR Cureus; 2022 May; 14(5):e25032. PubMed ID: 35719816 [TBL] [Abstract][Full Text] [Related]
9. Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism. Liu Z; Yu Y; Li X; Ross CA; Smith WW Pharmacol Res; 2011 May; 63(5):439-44. PubMed ID: 21237271 [TBL] [Abstract][Full Text] [Related]
10. Chronic dietary supplementation with turmeric protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-mediated neurotoxicity in vivo: implications for Parkinson's disease. Mythri RB; Veena J; Harish G; Shankaranarayana Rao BS; Srinivas Bharath MM Br J Nutr; 2011 Jul; 106(1):63-72. PubMed ID: 21473798 [TBL] [Abstract][Full Text] [Related]
11. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease. Oiwa Y; Yoshimura R; Nakai K; Itakura T Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170 [TBL] [Abstract][Full Text] [Related]
12. Curcumin's neuroprotective efficacy in Drosophila model of idiopathic Parkinson's disease is phase specific: implication of its therapeutic effectiveness. Phom L; Achumi B; Alone DP; Muralidhara ; Yenisetti SC Rejuvenation Res; 2014 Dec; 17(6):481-9. PubMed ID: 25238331 [TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effect of curcumin as evinced by abrogation of rotenone-induced motor deficits, oxidative and mitochondrial dysfunctions in mouse model of Parkinson's disease. Khatri DK; Juvekar AR Pharmacol Biochem Behav; 2016; 150-151():39-47. PubMed ID: 27619637 [TBL] [Abstract][Full Text] [Related]
15. The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease. Prediger RD; Aguiar AS; Moreira EL; Matheus FC; Castro AA; Walz R; De Bem AF; Latini A; Tasca CI; Farina M; Raisman-Vozari R Curr Pharm Des; 2011; 17(5):489-507. PubMed ID: 21375482 [TBL] [Abstract][Full Text] [Related]
16. Protective effects of curcumin against rotenone-induced rat model of Parkinson's disease: in vivo electrophysiological and behavioral study. Darbinyan LV; Hambardzumyan LE; Simonyan KV; Chavushyan VA; Manukyan LP; Badalyan SA; Khalaji N; Sarkisian VH Metab Brain Dis; 2017 Dec; 32(6):1791-1803. PubMed ID: 28695411 [TBL] [Abstract][Full Text] [Related]
17. Curcumin restores rotenone induced depressive-like symptoms in animal model of neurotoxicity: assessment by social interaction test and sucrose preference test. Madiha S; Haider S Metab Brain Dis; 2019 Feb; 34(1):297-308. PubMed ID: 30506334 [TBL] [Abstract][Full Text] [Related]
18. Mulberry fruit ameliorates Parkinson's-disease-related pathology by reducing α-synuclein and ubiquitin levels in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model. Gu PS; Moon M; Choi JG; Oh MS J Nutr Biochem; 2017 Jan; 39():15-21. PubMed ID: 27741433 [TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of IDPU (1-(7-imino-3-propyl-2,3-dihydrothiazolo [4,5-d]pyrimidin-6(7H)-yl)urea) in 6-OHDA induced rodent model of hemiparkinson's disease. Kumari N; Agrawal S; Kumari R; Sharma D; Luthra PM Neurosci Lett; 2018 May; 675():74-82. PubMed ID: 29567422 [TBL] [Abstract][Full Text] [Related]
20. Potential therapeutic effects of antagonizing adenosine A Motawi TK; Sadik NAH; Hamed MA; Ali SA; Khalil WKB; Ahmed YR Mol Cell Biochem; 2020 Feb; 465(1-2):89-102. PubMed ID: 31820278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]